We’re moving! Datasets in the NIAGADS database are being transitioned to the DSS database, click to learn more.

Biblio

Found 148 results
Author Keyword Title [ Type(Asc)] Year
Journal Article
P. Nowotny, Hinrichs, A. L., Smemo, S., Kauwe, J. S. K., Maxwell, T., Holmans, P., Hamshere, M., Turic, D., Jehu, L., Hollingworth, P., Moore, P., Bryden, L., Myers, A., Doil, L. M., Tacey, K. M., Gibson, A. M., McKeith, I. G., Perry, R. H., Morris, C. M., Thal, L., Morris, J. C., O'Donovan, M. C., Lovestone, S., Grupe, A., Hardy, J., Owen, M. J., Williams, J., and Goate, A., “Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.”, Am J Med Genet B Neuropsychiatr Genet, vol. 136B, no. 1, pp. 62-8, 2005.
M. Allen, Kachadoorian, M., Quicksall, Z., Zou, F., Chai, H. Seng, Younkin, C., Crook, J. E., V Pankratz, S., Carrasquillo, M. M., Krishnan, S., Nguyen, T., Ma, L., Malphrus, K., Lincoln, S., Bisceglio, G., Kolbert, C. P., Jen, J., Mukherjee, S., Kauwe, J. K., Crane, P. K., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Schellenberg, G. D., Parisi, J. E., Petersen, R. C., Graff-Radford, N. R., Dickson, D. W., Younkin, S. G., and Ertekin-Taner, N., “Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.”, Alzheimers Res Ther, vol. 6, no. 4, p. 39, 2014.
M. Ghani, Reitz, C., Cheng, R., Vardarajan, B. Narayan, Jun, G., Sato, C., Naj, A., Rajbhandary, R., San Wang, L. -, Valladares, O., Lin, C. - F., Larson, E. B., Graff-Radford, N. R., Evans, D., De Jager, P. L., Crane, P. K., Buxbaum, J. D., Murrell, J. R., Raj, T., Ertekin-Taner, N., Logue, M., Baldwin, C. T., Green, R. C., Barnes, L. L., Cantwell, L. B., M Fallin, D., Go, R. C. P., Griffith, P. A., Obisesan, T. O., Manly, J. J., Lunetta, K. L., M Kamboh, I., Lopez, O. L., Bennett, D. A., Hendrie, H., Hall, K. S., Goate, A. M., Byrd, G. S., Kukull, W. A., Foroud, T. M., Haines, J. L., Farrer, L. A., Pericak-Vance, M. A., Lee, J. H., Schellenberg, G. D., St George-Hyslop, P., Mayeux, R., and Rogaeva, E., “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
J. J. Corneveaux, Myers, A. J., Allen, A. N., Pruzin, J. J., Ramirez, M., Engel, A., Nalls, M. A., Chen, K., Lee, W., Chewning, K., Villa, S. E., Meechoovet, H. B., Gerber, J. D., Frost, D., Benson, H. L., O'Reilly, S., Chibnik, L. B., Shulman, J. M., Singleton, A. B., Craig, D. W., Van Keuren-Jensen, K. R., Dunckley, T., Bennett, D. A., De Jager, P. L., Heward, C., Hardy, J., Reiman, E. M., and Huentelman, M. J., “Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”, Hum Mol Genet, vol. 19, no. 16, pp. 3295-301, 2010.
J. R. Murrell, Price, B., Lane, K. A., Baiyewu, O., Gureje, O., Ogunniyi, A., Unverzagt, F. W., Smith-Gamble, V., Gao, S., Hendrie, H. C., and Hall, K. S., “Association of apolipoprotein E genotype and Alzheimer disease in African Americans.”, Arch Neurol, vol. 63, no. 3, pp. 431-4, 2006.
W. A. Kukull, Schellenberg, G. D., Bowen, J. D., McCormick, W. C., Yu, C. E., Teri, L., Thompson, J. D., O'Meara, E. S., and Larson, E. B., “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
D. Mastroeni, Sekar, S., Nolz, J., Delvaux, E., Lunnon, K., Mill, J., Liang, W. S., and Coleman, P. D., “ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.”, PLoS One, vol. 12, no. 7, p. e0177814, 2017.
C. - F. Lin, Naj, A. C., and San Wang, L. -, “Analyzing copy number variation using SNP array data: protocols for calling CNV and association tests.”, Curr Protoc Hum Genet, vol. 79, p. Unit 1.27., 2013.
R. A. Nafikov, Nato, A. Q., Sohi, H., Wang, B., Brown, L., Horimoto, A. R., Vardarajan, B. N., Barral, S. M., Tosto, G., Mayeux, R. P., Thornton, T. A., Blue, E., and Wijsman, E. M., “Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP.”, Genet Epidemiol, vol. 42, no. 6, pp. 500-515, 2018.
M. Victoria Fernández, Kim, J. Hun, Budde, J. P., Black, K., Medvedeva, A., Saef, B., Deming, Y., Del-Aguila, J., Ibañez, L., Dube, U., Harari, O., Norton, J., Chasse, R., Morris, J. C., Goate, A., and Cruchaga, C., “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
C. A. Reynolds, Hong, M. - G., Eriksson, U. K., Blennow, K., Wiklund, F., Johansson, B., Malmberg, B., Berg, S., Alexeyenko, A., Grönberg, H., Gatz, M., Pedersen, N. L., and Prince, J. A., “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
J. M. van der Walt, Dementieva, Y. A., Martin, E. R., Scott, W. K., Nicodemus, K. K., Kroner, C. C., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Small, G. W., Schmechel, D. E., P Doraiswamy, M., Gilbert, J. R., Haines, J. L., Vance, J. M., and Pericak-Vance, M. A., “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.
S. Swaminathan, Huentelman, M. J., Corneveaux, J. J., Myers, A. J., Faber, K. M., Foroud, T., Mayeux, R., Shen, L., Kim, S., Turk, M., Hardy, J., Reiman, E. M., and Saykin, A. J., “Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.”, PLoS One, vol. 7, no. 12, p. e50640, 2012.
J. H. Lee, Cheng, R., Graff-Radford, N., Foroud, T., and Mayeux, R., “Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.”, Arch Neurol, vol. 65, no. 11, pp. 1518-26, 2008.
G. W. Beecham, Bis, J. C., Martin, E. R., Choi, S. - H., Destefano, A. L., van Duijn, C. M., Fornage, M., Gabriel, S. B., Koboldt, D. C., Larson, D. E., Naj, A. C., Psaty, B. M., Salerno, W., Bush, W. S., Foroud, T. M., Wijsman, E., Farrer, L. A., Goate, A., Haines, J. L., Pericak-Vance, M. A., Boerwinkle, E., Mayeux, R., Seshadri, S., and Schellenberg, G., “The Alzheimer's Disease Sequencing Project: Study design and sample selection.”, Neurol Genet, vol. 3, no. 5, p. e194, 2017.
P. K. Crane, Foroud, T., Montine, T. J., and Larson, E. B., “Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.”, Alzheimers Dement, vol. 13, no. 12, pp. 1410-1413, 2017.
C. M. Karch, Ezerskiy, L. A., Bertelsen, S., and Goate, A. M., “Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.”, PLoS One, vol. 11, no. 2, p. e0148717, 2016.
M. Thambisetty, An, Y., and Tanaka, T., “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
C. M. Karch, Cruchaga, C., and Goate, A. M., “Alzheimer's disease genetics: from the bench to the clinic.”, Neuron, vol. 83, no. 1, pp. 11-26, 2014.
P. G. Ridge, Mukherjee, S., Crane, P. K., and Kauwe, J. S. K., “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
P. L. Kramer, Xu, H., Woltjer, R. L., Westaway, S. K., Clark, D., Erten-Lyons, D., Kaye, J. A., Welsh-Bohmer, K. A., Troncoso, J. C., Markesbery, W. R., Petersen, R. C., R Turner, S., Kukull, W. A., Bennett, D. A., Galasko, D., Morris, J. C., and Ott, J., “Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.”, Neurobiol Aging, vol. 32, no. 12, pp. 2113-22, 2011.
V. Busby, Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Harold, D., Turic, D., Jehu, L., Myers, A., Womick, M., Woo, D., Compton, D., Doil, L. M., Tacey, K. M., Lau, K. F., Al-Saraj, S., Killick, R., Pickering-Brown, S., Moore, P., Hollingworth, P., Archer, N., Foy, C., Walter, S., Lendon, C., Iwatsubo, T., Morris, J. C., Norton, J., Mann, D., Janssens, B., Hardy, J., O'Donovan, M., Jones, L., Williams, J., Holmans, P., Owen, M. J., Grupe, A., Powell, J., van Hengel, J., Goate, A., Van Roy, F., and Lovestone, S., “Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.”, Neuromolecular Med, vol. 5, no. 2, pp. 133-46, 2004.
J. H. Lee, Barral, S., Cheng, R., Chacon, I., Santana, V., Williamson, J., Lantigua, R., Medrano, M., Jimenez-Velazquez, I. Z., Stern, Y., Tycko, B., Rogaeva, E., Wakutani, Y., Kawarai, T., St George-Hyslop, P., and Mayeux, R., “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.